CBI Scene Blog

How to Align Management with Functional Areas of R&D

Posted by Evanna Payen on Apr 11, 2018 9:39:01 AM

While it's an issue that's not limited to the pharmaceutical industry, miscommunication between the "doers" - those actually performing clinical trials - and the "planners," who set and monitor the budget, is particularly prominent. While research and development in a non-pharmaceutical business can often be put on indefinite hold while funding is secured, clinical trials don't share that luxury. Variables such as timing, resources, and the ability to make adjustments if obstacles arise are freedoms all crucial to a given trial's success. This means, in turn, that "holding" isn't really a viable option. So how can the behind-the-scenes program teams work in tandem with those on the front lines?

Read More

Topics: Clinical, Compliance, Finance

Why Attend Medicaid 2014? The Reasons Are Endless...

Posted by Logan Fleck on May 13, 2014 10:43:00 AM

The Medicaid and Government Pricing Congress is one of the industry’s largest gatherings of managers and executives responsible for Contracts, Pricing, Finance, Accounting and Government Program Compliance. Over the past 15 years, almost 3,000 attendees have benefited from this valuable conference, which brings real world topics — including Healthcare Reform, Medicaid Expansion, Exchanges, Gross-to-Net, VA/DoD, 340B and Compliance — all into one forum. The session content and quality of presenters are always outstanding, and the opportunities to network with industry peers are invaluable. 

Read More

Topics: Finance

Leverage Technological Advancements to Achieve Financial Transformation

Posted by Sarah S on Feb 26, 2014 1:28:00 PM

Read More

Topics: Finance

Evolving Pharma Accounting Challenges in the International Arena

Posted by Katie S on Jan 31, 2014 4:08:00 PM

Read More

Topics: Finance

Creating & Maintaining the ‘Standard’: 5 Ways to Enhance Your GTN Performance

Posted by Leigh Anne Siino on Nov 27, 2013 2:39:00 PM

Read More

Topics: Finance

Harry Potter’s Severus Snape & Big Pharma, a Comparison

Posted by Daria Binder on Sep 18, 2013 11:25:00 AM

Read More

Topics: Brand & Digital Strategy, Medical Affairs, Patient Access, Distribution and Channel, Compliance, Finance

Musings on the AMP Final Rule & Other Fun Tidbits from Steven Moore

Posted by Jamie McHugh on May 3, 2013 12:08:00 PM

Read More

Topics: Government Pricing, Finance

Medical Device Excise Tax (MDET) Conversation Intensifies

Posted by Brittany Lake on Mar 29, 2013 11:23:00 AM

Read More

Topics: Compliance, Finance